Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity ALNY - Alnylam Pharmaceuticals, Inc.
3.83 B
LAST VALUE
2.53%
2 YEAR CAGR
19.45%
5 YEAR CAGR
24.72%
10 YEAR CAGR